Organic acidemia: Difference between revisions

From WikiMD's Wellness Encyclopedia

No edit summary
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Infobox medical condition (new)
{{Infobox medical condition
| name           = Organic acidemia
| name         = Organic Acidemia
| synonyms       =  '''Arganic aciduria'''
| image       =  
| image          =
| caption     =  
| alt            =  
| field       = [[Genetics]], [[Metabolism]]
| caption         =
| symptoms     = [[Vomiting]], [[lethargy]], [[hypotonia]], [[developmental delay]]
| pronounce      =  
| complications= [[Metabolic acidosis]], [[seizures]], [[coma]]
| field           =  
| onset       = [[Neonatal]] or [[infancy]]
| symptoms       =  
| duration     = Chronic
| complications   =  
| causes       = [[Genetic mutation]]
| onset           =  
| risks       = Family history
| duration       =
| diagnosis    = [[Newborn screening]], [[blood test]], [[urine test]]
| types          =  
| treatment   = [[Dietary management]], [[supplementation]], [[medication]]
| causes         =  
| prognosis   = Variable
| risks           =  
| frequency   = Rare
| diagnosis       =
| differential   =  
| prevention      =
| treatment       =  
| medication     =
| prognosis       =  
| frequency       =
| deaths          =  
}}
}}
'''Organic acidemia''', is a term used to classify a group of [[inborn error of metabolism|metabolic disorders]] which disrupt normal [[amino acid metabolism]], particularly [[branched-chain amino acids]], causing a buildup of acids which are usually not present.<ref name="bcoa">{{cite journal |vauthors =Ogier de Baulny H, Saudubray JM |title=Branched-chain organic acidurias |journal=Semin Neonatol. |volume=7 |issue=1 |pages=65–74 |year=2002 |pmid=12069539 |doi=10.1053/siny.2001.0087 }}</ref>


The branched-chain amino acids include [[isoleucine]], [[leucine]] and [[valine]].<ref name="bcoa" /> [[Organic acid]]s refer to the [[amino acid]]s and certain odd-chained [[fatty acid]]s which are affected by these disorders.
'''Organic acidemia''' refers to a group of [[metabolic disorders]] characterized by the accumulation of organic acids in the body due to defects in the [[metabolism]] of certain amino acids, fats, or carbohydrates. These disorders are typically inherited in an [[autosomal recessive]] manner and can lead to severe [[metabolic acidosis]] and other complications if not managed appropriately.


The four main types of organic acidemia are: [[methylmalonic acidemia]], [[propionic acidemia]], [[isovaleric acidemia]], and [[maple syrup urine disease]].<ref name="bcoa" />
==Pathophysiology==
Organic acidemias result from defects in the [[enzymes]] responsible for the breakdown of specific [[amino acids]], [[fatty acids]], or other compounds. This leads to the accumulation of organic acids in the [[blood]] and [[urine]], which can be toxic to the body. The accumulation of these acids can disrupt normal metabolic processes, leading to [[acidosis]], [[hypoglycemia]], and [[hyperammonemia]].


<youtube>
==Types of Organic Acidemia==
title='''{{PAGENAME}}'''
There are several types of organic acidemias, each associated with a specific enzyme deficiency:
movie_url=http://www.youtube.com/v/CROBzqPRJiw
&rel=1
embed_source_url=http://www.youtube.com/v/CROBzqPRJiw
&rel=1
wrap = yes
width=750
height=600
</youtube>


==Cause==
* '''[[Methylmalonic acidemia]] (MMA)''': Caused by a deficiency in the enzyme methylmalonyl-CoA mutase or defects in the metabolism of [[vitamin B12]].
Most of the organic acidemias result from defective [[autosome|autosomal]] [[gene]]s for various [[enzyme]]s important to amino acid [[metabolism]]. Neurological and physiological harm is caused by this impaired ability to synthesize a key enzyme required to break down a specific amino acid, or group of amino acids, resulting in acidemia and toxicity to specific organs systems. Most are inherited as [[autosomal recessive]] diseases.<ref>{{Cite journal|title = Suggested guidelines for the diagnosis and management of urea cycle disorders|url = http://www.ojrd.com/content/7/1/32/abstract|journal = Orphanet Journal of Rare Diseases|date = 2012-05-29|access-date = 2015-04-17|issn = 1750-1172|pmid = 22642880|pages = 32|volume = 7|issue = 1|doi = 10.1186/1750-1172-7-32|first = Johannes|last = Häberle|first2 = Nathalie|last2 = Boddaert|first3 = Alberto|last3 = Burlina|first4 = Anupam|last4 = Chakrapani|first5 = Marjorie|last5 = Dixon|first6 = Martina|last6 = Huemer|first7 = Daniela|last7 = Karall|first8 = Diego|last8 = Martinelli|first9 = Pablo S.|last9 = Crespo|pmc=3488504}}</ref><ref>{{Cite journal|title = Diagnosis and management of glutaric aciduria type I – revised recommendations|journal = Journal of Inherited Metabolic Disease|date = 2011|issn = 0141-8955|pmc = 3109243|pmid = 21431622|pages = 677–694|volume = 34|issue = 3|doi = 10.1007/s10545-011-9289-5|first = Stefan|last = Kölker|first2 = Ernst|last2 = Christensen|first3 = James V.|last3 = Leonard|first4 = Cheryl R.|last4 = Greenberg|first5 = Avihu|last5 = Boneh|first6 = Alberto B.|last6 = Burlina|first7 = Alessandro P.|last7 = Burlina|first8 = Marjorie|last8 = Dixon|first9 = Marinus|last9 = Duran}}</ref>
* '''[[Propionic acidemia]] (PA)''': Results from a deficiency in the enzyme propionyl-CoA carboxylase.
* '''[[Isovaleric acidemia]] (IVA)''': Caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase.
* '''[[Glutaric acidemia type I]] (GA1)''': Due to a deficiency in the enzyme glutaryl-CoA dehydrogenase.


==Diagnosis ==
==Clinical Presentation==
Organic acidemias are usually diagnosed in infancy, characterized by urinary excretion of abnormal amounts or types of [[organic acid]]s. The diagnosis is usually made by detecting an abnormal pattern of [[urine organic acids|organic acids]] in a urine sample by [[gas chromatography-mass spectrometry]]. In some conditions, the urine is always abnormal, in others the characteristic substances are only present intermittently. Many of the organic acidemias are detectable by [[newborn screening]] with tandem mass spectrometry.<ref>{{cite journal |vauthors=Dionisi-Vici C, Deodato F, Raschinger W, Rhead W, Wilcken B |title=Classical organic acidurias, propionic aciduria, methylmalonic aciduria, and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry |journal=J Inherit Metab Dis |volume=29 |issue=2–3 |pages=383–389 |year=2006 |pmid=16763906 |doi=10.1007/s10545-006-0278-z }}</ref>
Symptoms of organic acidemia can vary depending on the specific disorder and the severity of the enzyme deficiency. Common symptoms include:


These disorders vary in their [[prognosis]], from manageable to fatal, and usually affect more than one [[organ (anatomy)|organ]] system, especially the [[central nervous system]].
* [[Vomiting]]
* [[Lethargy]]
* [[Hypotonia]]
* [[Developmental delay]]
* [[Seizures]]
* [[Coma]]


Neurological damage and [[developmental delay]] are common factors in diagnosis, with associated symptoms ranging from [[poor feeding]] to slow [[Human development (biology)|growth]], [[lethargy]], [[vomiting]],
==Diagnosis==
[[dehydration]], [[malnutrition]], [[hypoglycemia]], [[hypotonia]], [[metabolic acidosis]], [[ketoacidosis]], [[hyperammonemia]], and if left untreated, [[death]].<ref>{{Cite book|title = Neurologic Emergencies in Infancy and Childhood|url = https://books.google.com/books?id=t0EfAwAAQBAJ&pg=PA326&dq=organic+acidemia+symptoms&hl=en&sa=X&ei=IisxVezTNKzIsATdfg&ved=0CB0Q6AEwAA#v=onepage&q=organic%20acidemia%20symptoms&f=false|publisher = Butterworth-Heinemann|date = 2013-10-22|access-date = 2015-04-17|isbn = 9781483193922|first = John M.|last = Pellock|first2 = Edwin C.|last2 = Myer}}</ref>
Diagnosis of organic acidemia is often made through [[newborn screening]] programs, which can detect elevated levels of specific organic acids in the blood. Further diagnostic tests include:


==Treatment==
* [[Blood test]]s to measure levels of organic acids and [[ammonia]].
Treatment or management of organic acidemias vary; eg see [[methylmalonic acidemia]], [[propionic acidemia]], [[isovaleric acidemia]], and [[maple syrup urine disease]].
* [[Urine test]]s to detect organic acid metabolites.
* [[Genetic testing]] to identify specific enzyme deficiencies.


As of 1984 there were no effective treatments for all of the conditions, though treatment for some included a limited [[protein]]/high [[carbohydrate]] diet, [[intravenous fluid]]s, amino acid substitution, vitamin supplementation, carnitine, induced [[anabolism]],<ref name="oat">{{cite journal |vauthors =Saudubray JM, Ogier H, Charpentier C, Depondt E, Couda FX, Munnich A, Mitchell G, Rey F, Rey J, Frazal J |title=Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update |journal=J Inherit Metab Dis |volume=7 |issue=Suppl. 1 |pages=2–9 |year=1984 |pmid=6434839 |doi=10.1007/978-94-009-5612-4_2}}</ref> and in some cases, tube-feeding.
==Management==
Management of organic acidemia involves dietary modifications and medical interventions to prevent metabolic crises:


As of 1993 [[beta-ketothiolase deficiency]] and other OAs were managed by trying to restore biochemical and physiologic homeostasis; common therapies included restricting diet to avoid the precursor amino acids and use of compounds to either dispose of toxic metabolites or increase enzyme activity.<ref name=Seashore1993>{{cite journal |last1=Seashore|first1=MR |last2=Pagon|first2=RA |last3=Adam|first3=MP |last4=Ardinger|first4=HH |last5=Bird|first5=TD |last6=Dolan|first6=CR |last7=Fong|first7=CT |last8=Smith|first8=RJH |last9=Stephens|first9=K |title=The Organic Acidemias: An Overview|date=1993|publisher=Gene Reviews (R) Seattle (WA): University of Washington, Seattle; 1993-2015.}}</ref>
* '''Dietary management''': Restriction of specific [[amino acids]] or [[proteins]] that cannot be properly metabolized.
* '''Supplementation''': Use of [[carnitine]] or [[vitamin B12]] supplements, depending on the specific disorder.
* '''Medication''': Use of medications to reduce ammonia levels or to provide alternative metabolic pathways.


==See also==
==Prognosis==
* {{sectionlink|ACAT1|Ketothiolase deficiency}}, another type of OA
The prognosis for individuals with organic acidemia varies depending on the type and severity of the disorder. Early diagnosis and management can improve outcomes and prevent severe complications.


==References==
==Research and Future Directions==
{{Reflist}}
Research is ongoing to better understand the genetic and biochemical basis of organic acidemias and to develop new treatments. [[Gene therapy]] and [[enzyme replacement therapy]] are potential future treatment options.


== External links ==
==See Also==
{{Medical resources
* [[Metabolic disorder]]
|  ICD10          = <!--{{ICD10|Xxx.x}}-->
* [[Inborn error of metabolism]]
|  ICD9            = <!--{{ICD9|xxx}}-->
* [[Amino acid metabolism]]
|  ICDO            =
 
|  OMIM            =  
==External Links==
|  DiseasesDB      =  
* [https://www.genome.gov/Genetic-Disorders/Organic-Acidemias National Human Genome Research Institute - Organic Acidemias]
|  MedlinePlus    =  
* [https://rarediseases.info.nih.gov/diseases/10753/organic-acidemias NIH Rare Diseases - Organic Acidemias]
|  eMedicineSubj  =  
 
|  eMedicineTopic  =
[[Category:Genetic disorders]]
|  MeSH            =
[[Category:Metabolic disorders]]
|  GeneReviewsNBK  =
[[Category:Pediatrics]]
|  GeneReviewsName =
{{rare diseases}}
|  Orphanet        = 289899
}}
* [https://web.archive.org/web/20100527193307/http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=oa-overview  GeneReviews/UW/NIH entry on Organic acidemias]
{{stub}}
{{Amino acid metabolic pathology}}
{{adapted}}
{{DEFAULTSORT:Organic Acidemia}}
[[Category:Amino acid metabolism disorders]]
[[Category:Rare diseases]]

Latest revision as of 01:08, 5 January 2025

Organic Acidemia
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Vomiting, lethargy, hypotonia, developmental delay
Complications Metabolic acidosis, seizures, coma
Onset Neonatal or infancy
Duration Chronic
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Newborn screening, blood test, urine test
Differential diagnosis N/A
Prevention N/A
Treatment Dietary management, supplementation, medication
Medication N/A
Prognosis Variable
Frequency Rare
Deaths N/A


Organic acidemia refers to a group of metabolic disorders characterized by the accumulation of organic acids in the body due to defects in the metabolism of certain amino acids, fats, or carbohydrates. These disorders are typically inherited in an autosomal recessive manner and can lead to severe metabolic acidosis and other complications if not managed appropriately.

Pathophysiology[edit]

Organic acidemias result from defects in the enzymes responsible for the breakdown of specific amino acids, fatty acids, or other compounds. This leads to the accumulation of organic acids in the blood and urine, which can be toxic to the body. The accumulation of these acids can disrupt normal metabolic processes, leading to acidosis, hypoglycemia, and hyperammonemia.

Types of Organic Acidemia[edit]

There are several types of organic acidemias, each associated with a specific enzyme deficiency:

Clinical Presentation[edit]

Symptoms of organic acidemia can vary depending on the specific disorder and the severity of the enzyme deficiency. Common symptoms include:

Diagnosis[edit]

Diagnosis of organic acidemia is often made through newborn screening programs, which can detect elevated levels of specific organic acids in the blood. Further diagnostic tests include:

Management[edit]

Management of organic acidemia involves dietary modifications and medical interventions to prevent metabolic crises:

  • Dietary management: Restriction of specific amino acids or proteins that cannot be properly metabolized.
  • Supplementation: Use of carnitine or vitamin B12 supplements, depending on the specific disorder.
  • Medication: Use of medications to reduce ammonia levels or to provide alternative metabolic pathways.

Prognosis[edit]

The prognosis for individuals with organic acidemia varies depending on the type and severity of the disorder. Early diagnosis and management can improve outcomes and prevent severe complications.

Research and Future Directions[edit]

Research is ongoing to better understand the genetic and biochemical basis of organic acidemias and to develop new treatments. Gene therapy and enzyme replacement therapy are potential future treatment options.

See Also[edit]

External Links[edit]

NIH genetic and rare disease info[edit]

Organic acidemia is a rare disease.